Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer ...

Guardant Health and Zephyr AI have partnered to advance the discovery of novel cancer biomarkers, as more precise tumour ...

Panelists discussed these questions during a recent Institute for Value-Based Medicine® event held in Nashville, Tennessee, ...

Lantern Pharma to Present AI-Driven Cancer Drug Development & Research Platforms at Inaugural AI for Biology and Medicine ...

The "Prostate Cancer Biomarkers Market Size and Growth Trends and Companies 2025-2033" has been added to ResearchAndMarkets.com's offering. The Prostate Cancer Biomarkers Market is expected to reach ...

Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly ...

The United States Prostate Cancer Biomarkers Market is projected to grow from $1.48 billion in 2024 to $3.54 billion by 2033, ...

Recombinant antibodies and rigorous validation standards are advancing cancer biomarker research, bridging the gap between early discovery and clinical translation. At every step of the biomarker ...

A rising wave of tumor-agnostic therapies were one of ESMO’s themes, highlighted during the opening press conference by Toni ...

Non-small cell lung cancer (NSCLC) remains a leading cause of cancer mortality despite recent advances in immunotherapy, particularly with immune checkpoint ...

The field of pancreatic cancer needs a measurable biological difference — a biomarker — to tell the difference between two subtypes of the disease with a timely and cost-effective clinical test. Fred ...